Open access
8,893
Views
161
CrossRef citations to date
0
Altmetric
Review
A novel, disruptive vaccination technology
Self-adjuvanted RNActive® vaccines
Karl-Josef Kallen CureVac GmbH; Tübingen, GermanyCorrespondence[email protected]
, Regina Heidenreich CureVac GmbH; Tübingen, Germany
, Margit Schnee CureVac GmbH; Tübingen, Germany
, Benjamin Petsch CureVac GmbH; Tübingen, Germany
, Thomas Schlake CureVac GmbH; Tübingen, Germany
, Andreas Thess CureVac GmbH; Tübingen, Germany
, Patrick Baumhof CureVac GmbH; Tübingen, Germany
, Birgit Scheel CureVac GmbH; Tübingen, Germany
, Sven D Koch CureVac GmbH; Tübingen, Germany
& Mariola Fotin-Mleczek CureVac GmbH; Tübingen, Germany
show all
Pages 2263-2276
|
Received 26 Mar 2013, Accepted 25 May 2013, Published online: 04 Jun 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.